 Mark Roback
Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Conscious Sedation | 23 | 2025 | 92 | 4.730 |
Why?
| | Ketamine | 18 | 2025 | 94 | 2.810 |
Why?
| | Hypnotics and Sedatives | 14 | 2025 | 200 | 2.600 |
Why?
| | Emergency Service, Hospital | 31 | 2025 | 2069 | 2.460 |
Why?
| | Anesthetics, Dissociative | 10 | 2025 | 30 | 1.660 |
Why?
| | Anesthesia | 3 | 2022 | 189 | 1.260 |
Why?
| | Laryngismus | 4 | 2025 | 10 | 1.140 |
Why?
| | Laryngoscopy | 2 | 2019 | 109 | 0.770 |
Why?
| | Autism Spectrum Disorder | 3 | 2025 | 395 | 0.760 |
Why?
| | Anesthesiology | 2 | 2024 | 87 | 0.710 |
Why?
| | Intubation, Intratracheal | 2 | 2019 | 257 | 0.700 |
Why?
| | Analgesia | 5 | 2018 | 94 | 0.690 |
Why?
| | Child, Preschool | 31 | 2025 | 11074 | 0.600 |
Why?
| | Airway Management | 1 | 2019 | 52 | 0.590 |
Why?
| | Emergency Medical Services | 3 | 2021 | 552 | 0.590 |
Why?
| | Child | 41 | 2025 | 21935 | 0.560 |
Why?
| | Intubation, Gastrointestinal | 1 | 2017 | 79 | 0.530 |
Why?
| | Infant | 28 | 2025 | 9465 | 0.530 |
Why?
| | Liability, Legal | 1 | 2016 | 44 | 0.500 |
Why?
| | Gastrostomy | 1 | 2017 | 117 | 0.500 |
Why?
| | Anti-Allergic Agents | 1 | 2016 | 46 | 0.500 |
Why?
| | Gastric Bypass | 1 | 2017 | 119 | 0.490 |
Why?
| | Fasting | 4 | 2019 | 281 | 0.480 |
Why?
| | Patient Transfer | 1 | 2016 | 176 | 0.430 |
Why?
| | Emergency Treatment | 4 | 2021 | 118 | 0.410 |
Why?
| | Hypersensitivity | 1 | 2016 | 257 | 0.410 |
Why?
| | Hospitalization | 4 | 2017 | 2199 | 0.400 |
Why?
| | Adolescent | 27 | 2025 | 21513 | 0.350 |
Why?
| | Vomiting | 6 | 2020 | 130 | 0.320 |
Why?
| | Atropine | 2 | 2010 | 23 | 0.310 |
Why?
| | Humans | 56 | 2025 | 137585 | 0.300 |
Why?
| | Pediatrics | 5 | 2015 | 1101 | 0.290 |
Why?
| | Midazolam | 4 | 2018 | 56 | 0.260 |
Why?
| | Propofol | 2 | 2017 | 73 | 0.250 |
Why?
| | Male | 30 | 2025 | 67762 | 0.250 |
Why?
| | Anesthetics, Intravenous | 2 | 2017 | 47 | 0.230 |
Why?
| | Etomidate | 2 | 2016 | 7 | 0.230 |
Why?
| | Premedication | 1 | 2004 | 44 | 0.230 |
Why?
| | Credentialing | 1 | 2024 | 18 | 0.220 |
Why?
| | Bradycardia | 1 | 2004 | 55 | 0.220 |
Why?
| | Consensus | 4 | 2024 | 683 | 0.220 |
Why?
| | Emergency Medicine | 2 | 2004 | 226 | 0.220 |
Why?
| | Intussusception | 1 | 2003 | 28 | 0.210 |
Why?
| | Orthopedic Procedures | 1 | 2006 | 216 | 0.210 |
Why?
| | Enema | 1 | 2003 | 47 | 0.210 |
Why?
| | Female | 26 | 2025 | 73304 | 0.200 |
Why?
| | Risk Factors | 12 | 2025 | 10388 | 0.200 |
Why?
| | Terminology as Topic | 2 | 2017 | 216 | 0.190 |
Why?
| | Administration, Intravenous | 3 | 2018 | 155 | 0.190 |
Why?
| | Prospective Studies | 10 | 2021 | 7604 | 0.190 |
Why?
| | Retrospective Studies | 14 | 2025 | 15657 | 0.180 |
Why?
| | Respiratory Tract Diseases | 2 | 2005 | 184 | 0.180 |
Why?
| | Infant, Newborn | 9 | 2021 | 6079 | 0.180 |
Why?
| | Hospitals, Pediatric | 5 | 2021 | 508 | 0.170 |
Why?
| | Excitatory Amino Acid Antagonists | 2 | 2018 | 100 | 0.170 |
Why?
| | Comorbidity | 2 | 2025 | 1622 | 0.170 |
Why?
| | Government Regulation | 1 | 2020 | 54 | 0.170 |
Why?
| | Epiglottitis | 1 | 2000 | 5 | 0.160 |
Why?
| | Fasciitis, Necrotizing | 1 | 2000 | 15 | 0.160 |
Why?
| | Preoperative Care | 2 | 2020 | 362 | 0.160 |
Why?
| | Administration, Intranasal | 2 | 2018 | 90 | 0.160 |
Why?
| | Racepinephrine | 1 | 2019 | 1 | 0.160 |
Why?
| | Croup | 1 | 2019 | 19 | 0.150 |
Why?
| | Infant Mortality | 1 | 2000 | 116 | 0.150 |
Why?
| | Chickenpox | 1 | 2000 | 83 | 0.150 |
Why?
| | Registries | 2 | 2025 | 2035 | 0.150 |
Why?
| | Depressive Disorder, Treatment-Resistant | 1 | 2018 | 10 | 0.150 |
Why?
| | Oral and Maxillofacial Surgeons | 1 | 2018 | 2 | 0.140 |
Why?
| | Endpoint Determination | 1 | 2018 | 77 | 0.140 |
Why?
| | Meningococcal Infections | 1 | 1998 | 25 | 0.140 |
Why?
| | Deep Sedation | 1 | 2017 | 14 | 0.140 |
Why?
| | Protein C | 1 | 1998 | 59 | 0.140 |
Why?
| | Patient Outcome Assessment | 1 | 2018 | 131 | 0.140 |
Why?
| | Bronchodilator Agents | 1 | 2019 | 252 | 0.140 |
Why?
| | Respiratory Sounds | 1 | 1998 | 125 | 0.140 |
Why?
| | Reference Standards | 1 | 2017 | 186 | 0.130 |
Why?
| | Radiography, Thoracic | 1 | 1998 | 167 | 0.130 |
Why?
| | Checklist | 1 | 2017 | 93 | 0.130 |
Why?
| | Ranitidine | 1 | 2016 | 14 | 0.130 |
Why?
| | Clinical Competence | 1 | 2024 | 1118 | 0.130 |
Why?
| | Diphenhydramine | 1 | 2016 | 37 | 0.130 |
Why?
| | Hematocele | 1 | 1996 | 1 | 0.130 |
Why?
| | Methylprednisolone | 1 | 2016 | 86 | 0.130 |
Why?
| | Splenic Rupture | 1 | 1996 | 5 | 0.120 |
Why?
| | Advisory Committees | 1 | 2017 | 219 | 0.120 |
Why?
| | Bronchiolitis | 1 | 1997 | 80 | 0.120 |
Why?
| | Nitrous Oxide | 1 | 2016 | 33 | 0.120 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 622 | 0.120 |
Why?
| | Cohort Studies | 6 | 2020 | 5742 | 0.120 |
Why?
| | Epinephrine | 1 | 2016 | 139 | 0.120 |
Why?
| | Scrotum | 1 | 1996 | 27 | 0.120 |
Why?
| | Dexmedetomidine | 1 | 2016 | 43 | 0.120 |
Why?
| | Patient Safety | 2 | 2018 | 314 | 0.120 |
Why?
| | Shock, Septic | 1 | 1998 | 219 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 2057 | 0.120 |
Why?
| | Diabetic Ketoacidosis | 3 | 2002 | 201 | 0.120 |
Why?
| | Edema | 1 | 1996 | 130 | 0.120 |
Why?
| | Anxiety | 1 | 2022 | 1035 | 0.110 |
Why?
| | Feasibility Studies | 1 | 2019 | 956 | 0.110 |
Why?
| | Standard of Care | 1 | 2015 | 72 | 0.110 |
Why?
| | Research Design | 2 | 2018 | 1139 | 0.110 |
Why?
| | Research | 1 | 2017 | 451 | 0.110 |
Why?
| | Respiration, Artificial | 1 | 2019 | 645 | 0.110 |
Why?
| | Blood | 1 | 1994 | 107 | 0.110 |
Why?
| | Haemophilus influenzae | 1 | 1994 | 63 | 0.110 |
Why?
| | Double-Blind Method | 3 | 2016 | 1993 | 0.110 |
Why?
| | Canada | 4 | 2018 | 418 | 0.110 |
Why?
| | Child Behavior Disorders | 1 | 2015 | 144 | 0.110 |
Why?
| | Spleen | 1 | 1996 | 514 | 0.110 |
Why?
| | Clinical Trials as Topic | 1 | 2018 | 1050 | 0.100 |
Why?
| | Wounds and Injuries | 1 | 2000 | 758 | 0.100 |
Why?
| | Streptococcus pneumoniae | 1 | 1994 | 169 | 0.100 |
Why?
| | Treatment Outcome | 5 | 2019 | 10811 | 0.100 |
Why?
| | Wounds, Nonpenetrating | 1 | 1996 | 278 | 0.100 |
Why?
| | Patient-Centered Care | 1 | 2017 | 530 | 0.100 |
Why?
| | Bacteremia | 1 | 1994 | 214 | 0.090 |
Why?
| | Oxygen | 1 | 1997 | 931 | 0.090 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 1000 | 0.090 |
Why?
| | Brain Edema | 2 | 2002 | 61 | 0.090 |
Why?
| | United States | 4 | 2021 | 14841 | 0.090 |
Why?
| | Patient Readmission | 1 | 1997 | 697 | 0.090 |
Why?
| | Analgesics | 2 | 2005 | 206 | 0.090 |
Why?
| | Infusions, Intravenous | 3 | 2009 | 413 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3284 | 0.090 |
Why?
| | Delphi Technique | 2 | 2024 | 280 | 0.090 |
Why?
| | Anesthesia Recovery Period | 2 | 2009 | 16 | 0.080 |
Why?
| | Practice Guidelines as Topic | 3 | 2018 | 1587 | 0.080 |
Why?
| | Clinical Protocols | 2 | 2015 | 271 | 0.080 |
Why?
| | Incidence | 7 | 2017 | 2804 | 0.080 |
Why?
| | Patient Discharge | 1 | 1997 | 897 | 0.080 |
Why?
| | Glycopyrrolate | 1 | 2010 | 2 | 0.080 |
Why?
| | Adjuvants, Anesthesia | 1 | 2010 | 12 | 0.080 |
Why?
| | Muscarinic Antagonists | 1 | 2010 | 29 | 0.080 |
Why?
| | Injections, Intramuscular | 2 | 2009 | 129 | 0.080 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2009 | 16 | 0.080 |
Why?
| | Neck Pain | 1 | 2009 | 26 | 0.080 |
Why?
| | Neck Injuries | 1 | 2009 | 21 | 0.080 |
Why?
| | Fentanyl | 2 | 2012 | 94 | 0.080 |
Why?
| | Quality Improvement | 1 | 2017 | 1178 | 0.080 |
Why?
| | Time Factors | 4 | 2020 | 6828 | 0.080 |
Why?
| | Adult | 6 | 2019 | 37929 | 0.080 |
Why?
| | Psychomotor Agitation | 1 | 2009 | 71 | 0.070 |
Why?
| | Ondansetron | 1 | 2008 | 16 | 0.070 |
Why?
| | Antiemetics | 1 | 2008 | 43 | 0.070 |
Why?
| | Respiratory System | 1 | 2009 | 157 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2015 | 847 | 0.070 |
Why?
| | Age Factors | 5 | 2021 | 3295 | 0.060 |
Why?
| | Foeniculum | 1 | 2005 | 1 | 0.060 |
Why?
| | Plant Poisoning | 1 | 2005 | 9 | 0.060 |
Why?
| | Logistic Models | 5 | 2016 | 2074 | 0.060 |
Why?
| | Methemoglobinemia | 1 | 2005 | 13 | 0.060 |
Why?
| | Colorado | 3 | 2005 | 4565 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2017 | 2654 | 0.060 |
Why?
| | Infusions, Parenteral | 1 | 2005 | 40 | 0.060 |
Why?
| | Guideline Adherence | 2 | 2019 | 556 | 0.060 |
Why?
| | Reflex | 1 | 2004 | 68 | 0.060 |
Why?
| | Chi-Square Distribution | 3 | 2010 | 530 | 0.050 |
Why?
| | Respiration Disorders | 1 | 2004 | 77 | 0.050 |
Why?
| | Competency-Based Education | 1 | 2024 | 73 | 0.050 |
Why?
| | Respiratory Aspiration | 2 | 2018 | 31 | 0.050 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 1066 | 0.050 |
Why?
| | Hypocapnia | 1 | 2001 | 8 | 0.040 |
Why?
| | Blood Urea Nitrogen | 1 | 2001 | 54 | 0.040 |
Why?
| | Injections, Intravenous | 2 | 2013 | 206 | 0.040 |
Why?
| | Recurrence | 1 | 2003 | 1060 | 0.040 |
Why?
| | Infant Equipment | 1 | 2000 | 9 | 0.040 |
Why?
| | Fever | 1 | 2021 | 306 | 0.040 |
Why?
| | Respiratory Aspiration of Gastric Contents | 1 | 2019 | 1 | 0.040 |
Why?
| | Corneal Diseases | 1 | 2000 | 35 | 0.040 |
Why?
| | Eye Injuries | 1 | 2000 | 45 | 0.040 |
Why?
| | Transportation of Patients | 1 | 2000 | 55 | 0.040 |
Why?
| | United States Food and Drug Administration | 1 | 2020 | 208 | 0.040 |
Why?
| | Risk Assessment | 3 | 2018 | 3457 | 0.040 |
Why?
| | Streptococcus pyogenes | 1 | 2000 | 45 | 0.040 |
Why?
| | Cholinergic Antagonists | 2 | 2009 | 30 | 0.040 |
Why?
| | Case-Control Studies | 3 | 2010 | 3556 | 0.040 |
Why?
| | American Dental Association | 1 | 2018 | 6 | 0.040 |
Why?
| | Prothrombin | 1 | 1998 | 26 | 0.040 |
Why?
| | Survival | 1 | 1998 | 38 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 2031 | 0.040 |
Why?
| | Platelet Count | 1 | 1998 | 86 | 0.040 |
Why?
| | Length of Stay | 1 | 2003 | 1215 | 0.040 |
Why?
| | Benzodiazepines | 2 | 2009 | 155 | 0.040 |
Why?
| | Anesthesiologists | 1 | 2018 | 28 | 0.040 |
Why?
| | Hematocrit | 1 | 1998 | 96 | 0.040 |
Why?
| | Radiology, Interventional | 1 | 2018 | 33 | 0.040 |
Why?
| | Resuscitation | 1 | 2000 | 251 | 0.030 |
Why?
| | Triage | 1 | 2000 | 222 | 0.030 |
Why?
| | Acute Disease | 2 | 2002 | 1007 | 0.030 |
Why?
| | Hypoglycemia | 1 | 2002 | 445 | 0.030 |
Why?
| | Hypoxia | 1 | 2004 | 1112 | 0.030 |
Why?
| | Physical Examination | 1 | 2018 | 241 | 0.030 |
Why?
| | Leukocyte Count | 1 | 1998 | 329 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2002 | 3715 | 0.030 |
Why?
| | Hospitals, General | 1 | 2016 | 22 | 0.030 |
Why?
| | Fibrinogen | 1 | 1998 | 168 | 0.030 |
Why?
| | Endotoxins | 1 | 1998 | 220 | 0.030 |
Why?
| | Multivariate Analysis | 3 | 2010 | 1509 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2000 | 1946 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2020 | 696 | 0.030 |
Why?
| | Rabbits | 1 | 1998 | 794 | 0.030 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2018 | 547 | 0.030 |
Why?
| | Diagnostic Errors | 1 | 1997 | 170 | 0.030 |
Why?
| | Hemoglobins | 1 | 1998 | 353 | 0.030 |
Why?
| | Trauma Severity Indices | 1 | 1996 | 106 | 0.030 |
Why?
| | Staphylococcus aureus | 1 | 2000 | 450 | 0.030 |
Why?
| | Heart Diseases | 1 | 1998 | 346 | 0.030 |
Why?
| | Societies, Medical | 1 | 2019 | 820 | 0.030 |
Why?
| | Spectrophotometry | 1 | 1994 | 61 | 0.030 |
Why?
| | Remission Induction | 1 | 2015 | 288 | 0.030 |
Why?
| | Odds Ratio | 1 | 2017 | 1070 | 0.030 |
Why?
| | Thrombosis | 1 | 1998 | 371 | 0.030 |
Why?
| | Heart Arrest | 1 | 2016 | 339 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2005 | 2111 | 0.020 |
Why?
| | Algorithms | 1 | 2019 | 1704 | 0.020 |
Why?
| | Databases, Factual | 1 | 2017 | 1357 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 1996 | 1483 | 0.020 |
Why?
| | Young Adult | 2 | 2017 | 13209 | 0.020 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2010 | 16 | 0.020 |
Why?
| | Switzerland | 1 | 2009 | 37 | 0.020 |
Why?
| | Pain | 1 | 2015 | 756 | 0.020 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2008 | 77 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 5472 | 0.020 |
Why?
| | Fractures, Bone | 1 | 2012 | 380 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 1998 | 4295 | 0.020 |
Why?
| | Documentation | 1 | 2008 | 194 | 0.020 |
Why?
| | Contraindications | 1 | 2006 | 90 | 0.020 |
Why?
| | Methylene Blue | 1 | 2005 | 24 | 0.020 |
Why?
| | Cyanosis | 1 | 2005 | 16 | 0.010 |
Why?
| | Foodborne Diseases | 1 | 2005 | 57 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2005 | 840 | 0.010 |
Why?
| | Bicarbonates | 1 | 2001 | 44 | 0.010 |
Why?
| | Random Allocation | 1 | 2001 | 353 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2000 | 329 | 0.010 |
Why?
| | Survival Analysis | 1 | 2002 | 1325 | 0.010 |
Why?
| | Fluorescein Angiography | 1 | 2000 | 151 | 0.010 |
Why?
| | Drug Interactions | 1 | 2000 | 410 | 0.010 |
Why?
| | Reference Values | 1 | 2000 | 816 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2001 | 267 | 0.010 |
Why?
| | Visual Acuity | 1 | 2000 | 356 | 0.010 |
Why?
| | Socioeconomic Factors | 1 | 2002 | 1289 | 0.010 |
Why?
| | Sex Factors | 1 | 2002 | 2071 | 0.010 |
Why?
| | Animals | 1 | 1998 | 36940 | 0.010 |
Why?
| | Mental Disorders | 1 | 2002 | 1077 | 0.010 |
Why?
|
|
Roback's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|